| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycosis Fungoides | 15 | 2022 | 170 | 3.010 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 14 | 2021 | 212 | 2.580 |
Why?
|
| Sezary Syndrome | 10 | 2022 | 80 | 2.490 |
Why?
|
| Skin Neoplasms | 21 | 2024 | 5821 | 1.200 |
Why?
|
| Dermatitis, Atopic | 9 | 2021 | 731 | 1.070 |
Why?
|
| Epidermis | 4 | 2019 | 528 | 0.830 |
Why?
|
| Keratinocytes | 13 | 2022 | 790 | 0.810 |
Why?
|
| Interleukins | 4 | 2019 | 782 | 0.650 |
Why?
|
| Aminoquinolines | 3 | 2017 | 107 | 0.630 |
Why?
|
| Activins | 1 | 2019 | 210 | 0.600 |
Why?
|
| Chemokines, CXC | 1 | 2017 | 422 | 0.500 |
Why?
|
| Mouth Mucosa | 1 | 2018 | 432 | 0.500 |
Why?
|
| Skin | 12 | 2022 | 4484 | 0.460 |
Why?
|
| Chemokines | 1 | 2017 | 960 | 0.420 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2018 | 592 | 0.360 |
Why?
|
| Up-Regulation | 5 | 2019 | 4124 | 0.350 |
Why?
|
| Oxonic Acid | 1 | 2009 | 31 | 0.330 |
Why?
|
| Tegafur | 1 | 2009 | 39 | 0.330 |
Why?
|
| Receptors, CCR4 | 2 | 2019 | 77 | 0.310 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2021 | 3080 | 0.290 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 1922 | 0.260 |
Why?
|
| Th2 Cells | 3 | 2021 | 1060 | 0.240 |
Why?
|
| Dermatitis | 2 | 2017 | 202 | 0.240 |
Why?
|
| Galectins | 2 | 2019 | 295 | 0.240 |
Why?
|
| Psoriasis | 3 | 2017 | 950 | 0.230 |
Why?
|
| Stomach Neoplasms | 2 | 2017 | 1459 | 0.230 |
Why?
|
| Pruritus | 2 | 2017 | 380 | 0.220 |
Why?
|
| Cisplatin | 1 | 2009 | 1651 | 0.210 |
Why?
|
| Case-Control Studies | 12 | 2021 | 22176 | 0.200 |
Why?
|
| RNA, Messenger | 9 | 2019 | 12795 | 0.200 |
Why?
|
| Cytokines | 5 | 2022 | 7396 | 0.190 |
Why?
|
| Cyclophilin A | 1 | 2021 | 58 | 0.190 |
Why?
|
| Chemokine CCL17 | 1 | 2021 | 26 | 0.190 |
Why?
|
| Antigens, Neoplasm | 2 | 2022 | 1993 | 0.190 |
Why?
|
| Serpins | 1 | 2022 | 247 | 0.180 |
Why?
|
| Prednisolone | 2 | 2018 | 326 | 0.180 |
Why?
|
| Receptors, CCR3 | 1 | 2019 | 62 | 0.170 |
Why?
|
| Neoplasm Staging | 5 | 2020 | 11121 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2872 | 0.160 |
Why?
|
| Anticarcinogenic Agents | 1 | 2021 | 250 | 0.160 |
Why?
|
| 4-1BB Ligand | 1 | 2018 | 29 | 0.160 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 42 | 0.160 |
Why?
|
| GATA6 Transcription Factor | 1 | 2018 | 50 | 0.160 |
Why?
|
| Serum Amyloid A Protein | 1 | 2018 | 127 | 0.150 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 48 | 0.150 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2017 | 22 | 0.150 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2018 | 78 | 0.150 |
Why?
|
| Purpura | 1 | 2018 | 117 | 0.150 |
Why?
|
| Thrombospondin 1 | 1 | 2019 | 257 | 0.150 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2017 | 899 | 0.150 |
Why?
|
| Middle Aged | 27 | 2021 | 220895 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 347 | 0.150 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5671 | 0.140 |
Why?
|
| Chemokine CCL4 | 1 | 2017 | 126 | 0.140 |
Why?
|
| HMGB1 Protein | 1 | 2018 | 137 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2017 | 127 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 2 | 2017 | 2645 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 615 | 0.140 |
Why?
|
| Syndecan-4 | 1 | 2016 | 45 | 0.140 |
Why?
|
| Interleukin-4 | 2 | 2017 | 1149 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 831 | 0.130 |
Why?
|
| Chemokine CCL5 | 1 | 2017 | 214 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11742 | 0.130 |
Why?
|
| Pemphigoid, Bullous | 1 | 2018 | 112 | 0.130 |
Why?
|
| HTLV-I Infections | 1 | 2016 | 103 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2017 | 3492 | 0.130 |
Why?
|
| Thyroiditis | 1 | 2016 | 86 | 0.130 |
Why?
|
| Biopsy | 5 | 2019 | 6766 | 0.130 |
Why?
|
| Chemokine CX3CL1 | 1 | 2016 | 63 | 0.130 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 306 | 0.130 |
Why?
|
| Cell Proliferation | 6 | 2021 | 10445 | 0.130 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 164 | 0.130 |
Why?
|
| Drug Eruptions | 1 | 2018 | 335 | 0.130 |
Why?
|
| Vitiligo | 1 | 2016 | 97 | 0.130 |
Why?
|
| Stomatitis | 1 | 2018 | 271 | 0.130 |
Why?
|
| Azepines | 1 | 2017 | 329 | 0.120 |
Why?
|
| Receptors, IgG | 1 | 2018 | 559 | 0.120 |
Why?
|
| Japan | 2 | 2016 | 1378 | 0.120 |
Why?
|
| Scleroderma, Localized | 1 | 2015 | 87 | 0.120 |
Why?
|
| Vascular System Injuries | 1 | 2018 | 246 | 0.120 |
Why?
|
| Male | 28 | 2021 | 360804 | 0.120 |
Why?
|
| Humans | 47 | 2024 | 761504 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2017 | 750 | 0.120 |
Why?
|
| Proteoglycans | 1 | 2017 | 803 | 0.110 |
Why?
|
| Interleukin-1 | 1 | 2018 | 1248 | 0.110 |
Why?
|
| Alopecia Areata | 1 | 2016 | 128 | 0.110 |
Why?
|
| Chemotaxis | 1 | 2017 | 598 | 0.110 |
Why?
|
| Macrophages | 3 | 2018 | 5769 | 0.110 |
Why?
|
| Receptors, Virus | 1 | 2017 | 640 | 0.110 |
Why?
|
| Interferon-alpha | 1 | 2017 | 921 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 8547 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 1342 | 0.110 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 652 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2019 | 794 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1175 | 0.100 |
Why?
|
| Tumor Escape | 1 | 2015 | 370 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2018 | 612 | 0.100 |
Why?
|
| Melanoma, Experimental | 1 | 2015 | 560 | 0.100 |
Why?
|
| Disease Progression | 5 | 2019 | 13506 | 0.100 |
Why?
|
| Triazoles | 1 | 2017 | 903 | 0.100 |
Why?
|
| Brazil | 1 | 2015 | 1230 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2017 | 912 | 0.100 |
Why?
|
| Female | 26 | 2021 | 392644 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3877 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1560 | 0.090 |
Why?
|
| Aged | 16 | 2023 | 169289 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2018 | 4021 | 0.090 |
Why?
|
| Colon | 1 | 2018 | 1792 | 0.090 |
Why?
|
| Colonoscopy | 1 | 2018 | 1394 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2015 | 1251 | 0.080 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 822 | 0.080 |
Why?
|
| Oxazolone | 2 | 2019 | 61 | 0.080 |
Why?
|
| Fatal Outcome | 2 | 2017 | 1834 | 0.080 |
Why?
|
| Adult | 16 | 2019 | 221177 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2020 | 11076 | 0.080 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 15842 | 0.080 |
Why?
|
| Young Adult | 7 | 2019 | 59243 | 0.070 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2018 | 562 | 0.070 |
Why?
|
| Lymphoma | 1 | 2015 | 1901 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12974 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10194 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 4580 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3617 | 0.060 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 16981 | 0.060 |
Why?
|
| Melanoma | 1 | 2023 | 5709 | 0.060 |
Why?
|
| Proteins | 1 | 2019 | 6032 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3466 | 0.060 |
Why?
|
| Mice | 7 | 2019 | 81525 | 0.060 |
Why?
|
| Animals | 11 | 2021 | 168459 | 0.050 |
Why?
|
| Prognosis | 3 | 2019 | 29625 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2009 | 2048 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2020 | 7856 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6935 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18965 | 0.050 |
Why?
|
| Disease Models, Animal | 5 | 2019 | 18252 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2021 | 2919 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 22169 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2021 | 9539 | 0.050 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2021 | 86 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2021 | 197 | 0.040 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2023 | 385 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2017 | 1893 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 641 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13639 | 0.040 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2024 | 328 | 0.040 |
Why?
|
| Receptors, CCR10 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Croton Oil | 1 | 2019 | 3 | 0.040 |
Why?
|
| Water Loss, Insensible | 1 | 2019 | 12 | 0.040 |
Why?
|
| Desmosomes | 1 | 2019 | 72 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2021 | 296 | 0.040 |
Why?
|
| beta-Defensins | 1 | 2018 | 59 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 4369 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 560 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 756 | 0.040 |
Why?
|
| Calgranulin A | 1 | 2018 | 80 | 0.040 |
Why?
|
| Skin Diseases, Infectious | 1 | 2018 | 76 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8320 | 0.040 |
Why?
|
| Ultraviolet Therapy | 1 | 2018 | 84 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2019 | 238 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14414 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2009 | 2827 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2023 | 1328 | 0.040 |
Why?
|
| Pyridones | 1 | 2023 | 809 | 0.040 |
Why?
|
| Growth Substances | 1 | 2019 | 768 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 695 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 411 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2019 | 718 | 0.030 |
Why?
|
| Cell Movement | 2 | 2019 | 5203 | 0.030 |
Why?
|
| Leucovorin | 1 | 2018 | 643 | 0.030 |
Why?
|
| Caspases | 1 | 2019 | 879 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2017 | 517 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 778 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 2016 | 777 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2023 | 1784 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2016 | 265 | 0.030 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 220 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 337 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 258 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 9031 | 0.030 |
Why?
|
| Arm | 1 | 2018 | 589 | 0.030 |
Why?
|
| Gastroscopy | 1 | 2017 | 211 | 0.030 |
Why?
|
| Camptothecin | 1 | 2018 | 591 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
| Nose | 1 | 2018 | 521 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1870 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1596 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 15601 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2016 | 392 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2017 | 3548 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2018 | 1641 | 0.030 |
Why?
|
| Eosinophils | 1 | 2018 | 950 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1626 | 0.030 |
Why?
|
| Cyclins | 1 | 2015 | 594 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 2057 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2850 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2015 | 819 | 0.030 |
Why?
|
| Scalp | 1 | 2015 | 389 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 88319 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 2626 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 22170 | 0.020 |
Why?
|
| Cell Count | 1 | 2016 | 1835 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 988 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3810 | 0.020 |
Why?
|
| Reference Values | 1 | 2018 | 4920 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1458 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2015 | 20570 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3595 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1600 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 2020 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4575 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 6534 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2161 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3602 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 4026 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2024 | 4652 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1897 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2015 | 1804 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6484 | 0.020 |
Why?
|
| Mast Cells | 1 | 2015 | 1392 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 2200 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2018 | 4003 | 0.020 |
Why?
|
| Viral Load | 1 | 2016 | 3332 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 80636 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2018 | 2538 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5869 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1886 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5671 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10090 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 3448 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 13380 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2019 | 23445 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3802 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9469 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 4352 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 39967 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2018 | 4398 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8465 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 21353 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5796 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6485 | 0.010 |
Why?
|
| Inflammation | 1 | 2022 | 10773 | 0.010 |
Why?
|
| Phenotype | 1 | 2019 | 16591 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9486 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36426 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30052 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2017 | 12128 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 64680 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 58976 | 0.010 |
Why?
|